Swiss All Share Index
16.307,04
PKT
-1,63
PKT
-0,01
%
Werbung
Analysen zu Swiss All Share Index-Werten
Datum | Rating | Analyst | |
---|---|---|---|
11.04.24 | Givaudan Sell | UBS AG | |
11.04.24 | Givaudan Neutral | JP Morgan Chase & Co. | |
11.04.24 | Givaudan Reduce | Baader Bank | |
11.04.24 | Givaudan Underperform | Jefferies & Company Inc. | |
10.04.24 | UBS Outperform | RBC Capital Markets | |
10.04.24 | DocMorris Buy | Jefferies & Company Inc. | |
10.04.24 | Novartis Buy | UBS AG | |
10.04.24 | DocMorris Add | Baader Bank | |
10.04.24 | DocMorris Buy | Warburg Research | |
09.04.24 | Roche Neutral | UBS AG | |
09.04.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
08.04.24 | Roche Equal Weight | Barclays Capital | |
08.04.24 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
08.04.24 | Swiss Re Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
05.04.24 | Zurich Insurance Overweight | Barclays Capital | |
04.04.24 | Novartis Buy | Jefferies & Company Inc. | |
04.04.24 | Novartis Buy | UBS AG | |
04.04.24 | Nestlé Underperform | Jefferies & Company Inc. | |
04.04.24 | Richemont Buy | Jefferies & Company Inc. | |
04.04.24 | UBS Outperform | RBC Capital Markets | |
04.04.24 | ams-OSRAM Buy | Jefferies & Company Inc. | |
03.04.24 | Swiss Re Sell | UBS AG | |
03.04.24 | Givaudan Sell | UBS AG | |
03.04.24 | Swiss Re Hold | Jefferies & Company Inc. | |
03.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
03.04.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
02.04.24 | Givaudan Underweight | Barclays Capital | |
02.04.24 | Richemont Overweight | Barclays Capital | |
02.04.24 | DocMorris Sell | UBS AG | |
02.04.24 | ams-OSRAM Equal Weight | Barclays Capital | |
02.04.24 | Richemont Buy | UBS AG | |
02.04.24 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
02.04.24 | Roche Underweight | JP Morgan Chase & Co. | |
28.03.24 | Zurich Insurance Hold | Jefferies & Company Inc. | |
28.03.24 | Richemont Buy | Jefferies & Company Inc. | |
28.03.24 | UBS Outperform | RBC Capital Markets | |
28.03.24 | Richemont Sector Perform | RBC Capital Markets | |
28.03.24 | Novartis Underweight | Barclays Capital | |
27.03.24 | UBS Buy | Goldman Sachs Group Inc. |